Round robin trial
Zytomed Systems regularly participates in round robin trials for immunohistochemistry, in situ hybridization and quantitative PCR, which are carried out by the Quality Assurance Initiative Pathology (QuIP), NordiQC and the European Society of Pathology (ESP). Please find current certificates here.
NordiQC Run 59 2020 „ASMA“
Actin alpha, Smooth Muscle (ASMA), Clone 1A4 (MSK030) – Assessment Results
NordiQC Run 59 2020 „CD45 (LCA)“
CD45 (LCA), Clone PD7/26 and 2B11 (MSK045) – Assessment Results
NordiQC Run C7 „PD-L1 (Keytruda ®, TPS/CPS)“
PD-L1, Clone CAL10 (RBK063) – Assessment Results
NordiQC Run 55 2019 „CK5“
Cytokeratin 5 & 14, Clone XM26 + LL002 (MSK106) – Assessment Results.
NordiQC Run 56 2019 „Melan A (MLA)“
MART-1 (Melan-A), Clone M2-7C10 (MSK056) – Assessment Results.
NordiQC Run C5 2019 „PD-L1 (uro)“
Focused on the accuracy of PD-L1 IHC assays in order to identify patients with urothelial carcinomas to be treated with Pembrolizumab as immune therapy, PD-L1, Clone CAL10 (RBK063) – Assessment Results.
NordiQC Run C5 2019 „PD-L1 (lung)“
Focused on the accuracy of PD-L1 IHC assays in order to identify patients with non-small cell lung carcinoma (NSCLC) benefitting from immune therapy with Pembrolizumab, PD-L1, Clone CAL10 (RBK063) – Assessment Results.
back to Certificates
